Lung cancer, Non small cell lung cancer (NSCLC)
Results
Phase 3
This study looked at pazopanib after chemotherapy for non small cell lung cancer that had spread. This study was supported by Cancer Research UK.
Recruitment start: 26 January 2012
Recruitment end: 1 August 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Mary O'Brien
Cancer Research UK
European Organisation for Research and Treatment of Cancer (EORTC)
GlaxoSmithKline (GSK)
NIHR Clinical Research Network: Cancer
This is Cancer Research UK trial number CRUKE/11/026
Last reviewed: 04 Feb 2016
CRUK internal database number: 8281
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
